泰利多米德对COVID-19患者有效性的分子机制解释:ACE2是一种新的ΔNp63α向基因

Laura Monteonofrio1, Ilaria Virdia1, Sara Pozzi2

  • 1Dipartimento Di Ricerca E Tecnologie Avanzate, Istituto Nazionale Tumori Regina Elena IRCCS, 00144, Rome, Italy.

Journal of molecular medicine (Berlin, Germany)
|September 18, 2024
PubMed
概括

thalidomide以p63-依赖的方式降低ACE2 (血管酶转化酶2),减少SARS-CoV-2的进入并减轻COVID-19相关的炎症. 这种药物为病毒感染提供了双重治疗方法.